The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Chronic Kidney Disease Market Over The Period 2026–2030?

The chronic kidney disease market size has experienced strong growth in recent times. This market is set to expand from $74.87 billion in 2025 to $79.43 billion in 2026, advancing at a compound annual growth rate (CAGR) of 6.1%. Historically, this expansion has been propelled by an increasing prevalence of diabetes and hypertension, enhanced availability of dialysis infrastructure, advancements in kidney function diagnostics, a heightened awareness of chronic renal disorders, and the broadening of nephrology care services.

The chronic kidney disease market is projected to experience robust expansion over the next few years. It is expected to reach $101.87 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.4%. This anticipated growth during the forecast period can be attributed to the increasing development of novel renal therapies, a rising demand for patient-centric dialysis options, the expansion of digital kidney health monitoring, a growing focus on transplant readiness, and increased investments in preventive nephrology. Significant trends identified for the forecast period include a heightened emphasis on early CKD detection, the increasing adoption of renoprotective drug therapies, a growing use of home dialysis solutions, the expansion of multidisciplinary care models, and an enhanced focus on slowing disease progression.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

What Underlying Factors Are Accelerating The Growth Of The Chronic Kidney Disease Market?

The rising occurrence of kidney conditions is projected to boost the expansion of the chronic kidney disease market in the future. Kidney ailments encompass a range of disorders that impact the kidneys’ ability to function and their physical makeup. Treatment for kidney disease aims to regulate patients’ blood pressure and reduce protein leakage, thereby preventing the worsening of kidney damage, alleviating symptoms, and averting complications. For example, data from June 2023, provided by Kidney Research UK, a UK-based charity focused on funding kidney disease research, indicates that by 2033, the number of individuals suffering from CKD stages 3–5 is anticipated to reach approximately 3.9 million. Consequently, the expanding occurrence of kidney disease is fueling the growth within the chronic kidney disease market.

How Is The Chronic Kidney Disease Market Divided Into Its Major Segments?

The chronic kidney disease market covered in this report is segmented –

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-Ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Key Developments And Trends Are Impacting The Chronic Kidney Disease Market?

Major companies operating in the chronic kidney disease market are increasingly forming strategic alliances to investigate the effectiveness and safety of an enhanced Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. Such partnerships involve organizations utilizing their respective capabilities and assets to gain shared advantages and accomplishments. As an illustration, in June 2023, AWAK Technologies Pte Ltd., a medical technology firm based in Singapore, established a collaboration with Singapore General Hospital Pte Ltd. (SGH), an academic health science center and hospital company also located in Singapore. Through this alliance, their goal is to transform the detection, care, and control of kidney disease. This includes working on the creation and evaluation of AWAK PD, a wearable and highly portable peritoneal dialysis (PD) system, designed to enable individuals with end-stage kidney disease to perform dialysis both at home and while traveling.

Who Are The Prominent Organizations Shaping The Chronic Kidney Disease Market?

Major companies operating in the chronic kidney disease market are Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Read the full chronic kidney disease market report here:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Which Region Is Projected To Dominate The Chronic Kidney Disease Market During The Forecast Period?

North America was the largest region in the chronic kidney disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chronic Kidney Disease Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

Browse Through More Reports Similar to the Global Chronic Kidney Disease Market 2026, By The Business Research Company

Peripheral Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-peripheral-neuropathy-treatment-global-market-report

Optic Nerve Disorders Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model